The Australian & New Zealand journal of obstetrics & gynaecology

Aust N Z J Obstet Gynaecol · ISSN (e) 1479-828X · 287 papers in corpus
other 2024
doi:10.1111/ajo.13869 ·PMID:39058265

The article by Ellis and Wood ‘A decade to wait’1 has added to the focus of energies on identifying and reducing the delay in diagnosis of endometriosis for those suffering pelvic pain. Such anonymous, retrospective, self-report surveys hav…

other 2023
doi:10.1111/ajo.13768 ·PMID:37905943

AIMS: The Raising Awareness Tool for Endometriosis (RATE) was developed to facilitate discussions with health providers regarding endometriosis-associated symptoms. We aim to evaluate the acceptability of the RATE by general practitioners (…

other 2023
doi:10.1111/ajo.13726 ·PMID:37466137

With 11.4% of women, girls and the gender-diverse community affected,1 endometriosis is a major contributor to morbidity globally. Australia is 80% of the way through the first five-year National Actional Plan on Endometriosis (NAPE), launc…

other 2023
doi:10.1111/ajo.13642 ·PMID:36691911
observational 2023
doi:10.1111/ajo.13705 ·PMID:37264738

BACKGROUND: A significant proportion of patients with endometriosis require surgery for management of the disease. AIMS: We aimed to assess the trend and regional variation in day surgeries for endometriosis across Canada and to identify p…

other 2023
doi:10.1111/ajo.13643 ·PMID:36788708

Endometriosis affects about 10% of reproductively aged women and up to 40–50% of infertile women. That an association exists between endometriosis and fertility is undisputed. Endometriosis is thought to create an inflammatory pelvic milieu…

other 2023
doi:10.1111/ajo.13699 ·PMID:37226362

In Australia, endometriosis affects one in nine women and those assigned female at birth. Although endometriosis is more common than conditions such as diabetes, research funding for endometriosis research has historically been low in compa…

meta-analysis 2023
doi:10.1111/ajo.13755 ·PMID:37753632

BACKGROUND: Endometriosis is a chronic, inflammatory condition characterised by the presence of endometrial-like tissue outside the uterine cavity. Given the multi-system nature of the disease and the potential for significant negative impa…

observational 2023
doi:10.1111/ajo.13682 ·PMID:37185818

BACKGROUND: Transvaginal hysterosalpingo-foam sonography (HyFoSy) assesses tubal patency in an outpatient setting and without ionising radiation, unlike traditional hysterosalpingography (HSG) under fluoroscopy. Like HSG, HyFoSy may be comp…

other 2023
doi:10.1111/ajo.13765 ·PMID:37934764

A reliable non-invasive biomarker for endometriosis is highly likely in the coming years. In the lead-up to this, clinicians need to be aware of commercially available tests as they become accessible, be aware of the level of evidence to su…

observational 2023
doi:10.1111/ajo.13766 ·PMID:37905892

INTRODUCTION: Endometriosis is an under-researched disease, with Aotearoa-specific data severely lacking. Current estimates of parameters such as rates of endometriosis diagnosis, indication for surgery and sites of disease are based on int…

observational 2023
doi:10.1111/ajo.13730 ·PMID:37427888

BACKGROUND: In the most severe stage of endometriosis, Stage IV, intestinal involvement is common. The true prevalence of endometriotic disease of the appendix in this population is not well described. A macroscopically normal looking appen…

observational 2023
doi:10.1111/ajo.13683 ·PMID:37101224

BACKGROUND: Whereas symptomatic endometriosis may affect work performance, the impact of endometriosis in the general community is not known. AIMS: The associations between endometriosis and each of sick leave and work ability, were invest…

other 2023
doi:10.1111/ajo.13762 ·PMID:37905841

BACKGROUND: Laparoscopic reverse submucosal dissection (LRSD) is a standardised surgical technique for removal of rectosigmoid endometriosis which optimises the anatomical dissection plane for excision of endometriotic nodules. AIM: This c…

observational 2022
doi:10.1111/ajo.13596 ·PMID:35950448

BACKGROUND: Central sensitisation (CS) leads to pain amplification and impacts on the management of pelvic pain (PP). Identification of CS in patients with PP may provide additional treatment pathways and improve patient outcomes. AIMS: Th…

other 2022
doi:10.1111/ajo.13517 ·PMID:36004419
other 2022
doi:10.1111/ajo.13448 ·PMID:35174879
observational 2022
doi:10.1111/ajo.13498 ·PMID:35166382

BACKGROUND: Management for gynaecological cancers often includes removal of the reproductive organs and/or the use of gonadotoxic therapies resulting in sub-fertility. Oncofertility and discussion of fertility preservation in these patients…

observational 2022
doi:10.1111/ajo.13618 ·PMID:36225109

AIMS: To evaluate morcellation practices among Fellows of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). MATERIALS AND METHODS: RANZCOG Fellows were invited to complete an online survey. This an…

observational 2022
doi:10.1111/ajo.13560 ·PMID:35754341

AIMS: The extent to which maternal transmission of primary dysmenorrhoea is genetically determined in adolescents and young women has yet to be determined. We aimed to assess heritability and associations relevant to primary pain syndromes …

other 2022
doi:10.1111/ajo.13451 ·PMID:35174877
observational 2022
doi:10.1111/ajo.13576 ·PMID:35726738

BACKGROUND: Add-ons at the time of in vitro fertilisation (IVF) have become commonplace, despite a general lack of evidence that they are effective and safe. The 'Colorado Protocol' is a commonly used add-on consisting of aspirin, steroid a…

other 2022
doi:10.1111/ajo.13447 ·PMID:34677826

AIMS: The aim of this study is to extend understandings of the impact of surgically diagnosed endometriosis on women's social lives, work and education. METHODS: Participants (N = 200; average age: 27.1 years (±6.72)) were recruited from a…

observational 2022
doi:10.1111/ajo.13524 ·PMID:35435253

BACKGROUND: To better understand the potential role of social media (SM) as a self-management tool for individuals with endometriosis and to assess its current use by endometriosis patients. AIMS: The primary outcome was use of SM for heal…

other 2022
doi:10.1111/ajo.13515 ·PMID:35274292

BACKGROUND: Adenomyosis is a benign disorder defined by ectopic endometrial glands within the uterine myometrium. A study by Mooney et al reported the myometrial-cervical ratio (MCR), a novel ultrasound measurement that was found to improve…